EFTR - eFFECTOR updates Phase 1/2 data for breast cancer therapy
2023-12-08 09:04:17 ET
More on eFFECTOR Therapeutics
- eFFECTOR stock rises after FDA fast track status for breast cancer therapy
- Seeking Alpha’s Quant Rating on eFFECTOR Therapeutics
- Historical earnings data for eFFECTOR Therapeutics
- Financial information for eFFECTOR Therapeutics
For further details see:
eFFECTOR updates Phase 1/2 data for breast cancer therapy